Goldman Sachs’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-2,850,551
Closed -$538K – 6020
2024
Q1
$538K Sell
2,850,551
-1,076,339
-27% -$244K ﹤0.01% 4718
2023
Q4
$638K Buy
3,926,890
+3,895,774
+12,520% +$1.29M ﹤0.01% 4622
2023
Q3
$13.8K Sell
31,116
-416,767
-93% -$190K ﹤0.01% 5384
2023
Q2
$165K Buy
447,883
+343,766
+330% +$293K ﹤0.01% 5239
2023
Q1
$189K Sell
104,117
-600,659
-85% -$1.31M ﹤0.01% 5317
2022
Q4
$1.46M Sell
704,776
-192,267
-21% -$607K ﹤0.01% 4164
2022
Q3
$2.7M Buy
897,043
+32,948
+4% +$117K ﹤0.01% 3709
2022
Q2
$2.77M Buy
864,095
+7,662
+0.9% +$41.5K ﹤0.01% 3755
2022
Q1
$5.52M Buy
856,433
+27,356
+3% +$247K ﹤0.01% 3256
2021
Q4
$11.1M Sell
829,077
-280,755
-25% -$3.09M ﹤0.01% 2665
2021
Q3
$13.1M Buy
+1,109,832
New +$17.5M ﹤0.01% 2452

Other funds holding HLTH

Goldman Sachs's HLTH Position: Q2 2024 in Review

Goldman Sachs sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 2,850,551 shares — an estimated $538K sold.

Goldman Sachs first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $13.1M in Q3 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Goldman Sachs reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 2,850,551 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $538K.
  • Goldman Sachs first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Goldman Sachs's Cue Health Inc. Common Stock position peaked at $13.1M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.